| Literature DB >> 32761297 |
Rachel Yelk Woodruff1, Andrew Hill2, Suzanne Marks2, Thomas Navin2, Roque Miramontes2.
Abstract
Increased testing and treatment of latent tuberculosis infection (LTBI) among US-residents who were born (or lived) in countries with high rates of TB can hasten progress toward TB elimination. We calculated LTBI prevalence using QuantiFERON®-TB Gold In-Tube results from the 2011 to 2012 National Health and Nutrition Examination Survey (NHANES). LTBI prevalence was highest for persons born in India (31.7%, 95% confidence interval [21.2, 44.5]). Non-Hispanic white persons had the lowest LTBI prevalence (6.3% [1.9, 18.9]). TB reactivation rate, defined as the number of TB cases not associated with recent transmission per 100 person-years of life with LTBI, was highest for persons born in Vietnam [0.183 (0.117, 0.303)]. Reactivation rates were lower among persons who had resided in the United States for ≥ 10 years than among those who had resided for < 10 years. Results among high risk populations can guide LTBI targeted testing and treatment among non-U.S.-born residents.Entities:
Keywords: LTBI; Latent tuberculosis infection; Non-U.S.-born; TB reactivation
Mesh:
Year: 2021 PMID: 32761297 PMCID: PMC7862421 DOI: 10.1007/s10903-020-01065-8
Source DB: PubMed Journal: J Immigr Minor Health ISSN: 1557-1912